Clinical Trials

New Search
Title   Safety Study of Gene Modified Donor T-cells Following TCR Alpha Beta Depleted Stem Cell Transplant
Disease/Condition   Blood and Bone Marrow Cancer
Eligibility Criteria   Ages Eligible for Study: 3 Months to 21 Years (Child, Adult) Genders Eligible for Study: Both Accepts Healthy Volunteers: No Click here for eligibility requirements
Principal Investigator   Kris Mahadeo, MD
Contact Name   Ruth Santizo
Phone   (718) 741-2287
Contact Email
IRB/Protocol Number   IRB# 15-11-347
Status   Enrolling
Adult Clinical Trial   No
Pediatric Clinical Trial   Yes